Australia, Sept. 17 -- Fate Therapeutics Inc., owns the trademark (2665877) for 'SWORD AND SHIELD' till Jan. 23, 2036.
Status: protected:
Registered/protected
Classes: 5 [Therapeutic preparations, namely, cellular immunotherapies for cancer, autoimmune diseases and transplant rejections.], 42 [Medical and clinical research and development services in the field of cellular immunotherapies; consulting services in the field of cellular immunotherapies; medical laboratory, research, pre-clinical, and clinical testing services, namely, providing medical laboratory, research, pre-clinical, and clinical testing services for others.] and 44 [Providing information, namely, providing medical and scientific information in the field of cellular immun...